IngredientsPetunidin (abbreviation: Pt), like Europinidin and Malvidin, is derived from Delphinidin and is an O-methylated anthocyanidin of the 3-hydroxy type. It is a natural organic compound, a dark-red or purple water-soluble pigment found in many red berries. The name of the molecule itself is derived from the word "Petunia," the ornamental flowering plant in which it was first identified and characterized.
The basic structure of the parent nucleus of anthocyanins is a highly conjugated 2-phenylbenzopyran cation; the two benzene rings are connected by three carbon atoms to form a C6–C3–C6 skeleton, which is the anthocyanin motif. The chemical structures of the six common anthocyanins differ from each other at positions 3′ and 5′ of the B-ring. Petunidin is specifically characterized by a hydroxyl group at the 3′ position and a methoxyl group at the 5′ position of the B-ring, which distinguishes it structurally from its biosynthetic precursor delphinidin (which has hydroxyl groups at both positions) and from the closely related malvidin (which has methoxyl groups at both positions).
Petunidin is derived from delphinidin by methylation, a biosynthetic step catalyzed by a specific enzyme. Petunidin could form in the exocarp of fruits from delphinidin, with an anthocyanin flavonoid O-methyltransferase (Catechol-O-methyl transferase) catalyzing the B-ring methylation and S-Adenosyl-L-methionine serving as methyl donor.
Petunidin accounts for approximately 7% of the anthocyanidin content in nature, making it one of the six most widely distributed anthocyanidins in plants. Delphinidin and its derivatives, petunidin and malvidin, are the sources of blue and purple pigments in plants.
Most anthocyanins have a molecular weight ranging from 400 to 1200 g/mol. Anthocyanins have a positive charge in their structures at an acidic pH and exist primarily as the stable flavylium cation when the pH is below 2. In nature, petunidin is rarely found as a free aglycone; free anthocyanidin is rare in natural conditions and often exists in the form of a glycoside. The most common glycoside forms include petunidin-3-O-glucoside (Pt3glc), petunidin-3-O-galactoside, petunidin-3-O-arabinoside, petunidin-3-O-rutinoside, and various acylated derivatives. Petunidin is an important anthocyanidin that commonly occurs as 3-O-glycosides in dietary sources, including fruits, seeds, and beverages.
Petunidin is found in many red berries including chokeberries (Aronia sp.), Saskatoon berries (Amelanchier alnifolia), different species of grape (for instance Vitis vinifera, or muscadine, Vitis rotundifolia), and is also part of the pigments responsible for the petal colors in many flowers.
Bilberries and blueberries contain high concentrations of petunidin and are an extremely good source. Berries and grapes are widely used in wine making; for example, muscadine is a major source of petunidin used in making artisan wine in Florida.
A total of 46 types of flavonoids have been isolated from black goji berries, including 37 types of anthocyanins. Anthocyanin content comparisons have revealed that black goji berries contain 1.60–6.25 mg/g anthocyanin, whereas raspberries and grapes contain 0.3–0.6 mg/g and 0.40–0.70 mg/g anthocyanin, respectively. Dry black goji berries contain eight types of anthocyanins with pelargonidin, petunidin, malvidin, and delphinidin as the parent cores, and petunidin as the main component.
Petunidin gives Indigo Rose tomatoes the majority of their deep purple color when the fruits are exposed to sunlight. Petunidin glucoside concentrations ranging from 0.7–115.0 mg/100 g have been identified among various black bean cultivars. In purple wheat, cyanidin-3-glucoside and petunidin-3-glucoside were found in relatively high concentrations in comparison to other anthocyanins.
Anthocyanins in berries are mainly glycosides of cyanidin, delphinidin, peonidin, pelargonidin, malvidin, and petunidin. They are abundant in various colored fruits such as berries, cherries, plums, figs, and dark-colored leafy and root vegetables like eggplant, purple cabbage, purple potatoes, and red onions.
In food and supplement contexts, petunidin is not generally isolated and consumed as a purified compound. Rather, it is consumed as part of whole anthocyanin-rich foods or extracts. Anthocyanins extracted from plants have been used as food additives. Food additive E163 is one of the commercial additives derived from fruit anthocyanins such as grape skin. It is a purple food additive for use in producing purple-colored jam, confectioneries, and beverages. Petunidin contributes to this E163 class alongside related anthocyanins. As a dietary supplement, petunidin is most often encountered as a constituent of standardized berry extracts (e.g., bilberry extract, black currant extract, elderberry extract, and grape skin extract), in which total anthocyanin content — rather than petunidin specifically — is typically the standardized parameter.
Petunidin as an isolated compound was not known or used in pre-modern traditions; its chemical identity was established in the twentieth century. However, the plant sources richest in petunidin have long histories of medicinal, culinary, and dyeing use in multiple cultures. Understanding the "traditional use" of petunidin therefore requires contextualizing it within the broader traditional use of anthocyanin-rich plants.
Some of these flowers have been traditionally used as folk medicine, as colorants, and as food. In addition to traditional usage, red, purple, and blue-colored fruits are commonly consumed for their beneficial effects. Blue, red, and purple colored pigments extracted from flowers, fruits, and vegetables have traditionally been used as dye and food colorants. Besides being used as natural colorants, some of the anthocyanin-rich flowers and fruits have been traditionally used as medicine to treat various diseases.
Around the world, many plants have been used for thousands of years in traditional medicines for the prevention and treatment of diseases or to maintain good health. Among the most relevant petunidin-containing plants, bilberry (Vaccinium myrtillus) has a documented history of use in European herbal medicine dating back centuries, where it was used for conditions involving the eyes, circulation, and digestive tract. Black goji berry (Lycium ruthenicum) has a significant place in Traditional Chinese Medicine, where it has been used as a tonic herb.
Anthocyanin-rich black carrot, red cabbage, and purple potato are potential functional foods that have been consumed for prevention of diseases. These food traditions, spanning Europe, Asia, and the Americas, predate any knowledge of petunidin's chemical identity but constitute the historical context in which petunidin-containing plants were valued.
The formal chemical characterization and naming of petunidin as a distinct molecular entity belongs to the modern era of analytical chemistry and plant pigment research, rather than to any traditional medicinal system. As a result, no classical monograph (e.g., German Commission E, ESCOP, WHO monograph) exists specifically for petunidin itself; such documents exist for the whole plant materials (e.g., bilberry) in which it is found.
Anthocyanins are comprised of two or three moieties: an aglycone (also known as anthocyanidin), one or more sugars, and possibly acyl acids. They are all based on the 2-phenylbenzoflavylium cation backbone. Some of the structural diversity arises from the extent and substitution pattern of hydroxylation or methoxylation of the aromatic rings in the aglycone.
In the case of petunidin specifically, the partial methylation of the B-ring (one methoxyl group rather than zero or two) confers intermediate stability relative to delphinidin and malvidin. The production of specific metabolites, specifically O-methylated metabolites from malvidin and petunidin, may increase their bioactivity. This methoxylation also influences the compound's stability during gastrointestinal transit: in one study where ileostomists were fed bilberry, malvidin and petunidin glycosides with methoxyl groups on the B-ring were recovered in greater quantities in ileal fluid than cyanidin and delphinidin glycosides comprising only hydroxyl groups, highlighting the increased stability/reduced absorption dynamic associated with B-ring methoxylation.
A computational investigation on the structure and antioxidant property of petunidin (PT) was performed under DFT/B3LYP/6-31+G(d,p). PT has a drug score of +0.804, which indicates its drug-like nature.
The antioxidant property of PT was well explained by the hydrogen atom transfer (HAT) mechanism, and it has been found that the electron-releasing substituents decrease the bond dissociation enthalpy (BDE) value. PT has the lowest BDE value at the C3 position, confirmed by the lowest pKa value, high atomic charge, and lowest bond order. PT easily donates the hydrogen atom and exists in the deprotonated form in blood, as the pKa value at C3 is less than the pH value of blood.
PT shows no violation to Lipinski's rule of 5, indicating its nature as an orally admissible drug. Moreover, PT has considerable bioactivity against nuclear receptor ligands, while it shows only moderate activity towards GPCR and ion channel modulators. It also shows moderate activity as an enzyme inhibitor and protease inhibitor but shows considerable activity as a kinase inhibitor.
Computational analysis clearly shows that PT is nonmutagenic, nontumorigenic, and nonirritant. PT shows good solubility (−2.328). The positive value for drug score (0.804) indicates that PT can act as a potential drug.
At the cellular and molecular level, petunidin has been shown in preclinical models to modulate several key inflammatory signaling pathways. Petunidin pre-treatment significantly reduced LPS-induced cytokine secretion in BV2 cells and primary retinal microglia, as well as lipocalin 2 (LCN2) upregulation in BV2 cells, by suppressing activation of O-GlcNAc modification and activation of NF-κB. Further study revealed that petunidin inactivated NF-κB by down-regulating OGT in BV2 cells, indicating that the protective effect of petunidin against LPS-induced retinal microglia inflammatory response was achieved by regulating the OGT/NF-κB/LCN2 axis.
Petunidin-3-O-glucoside (Pt3glc) is a kind of anthocyanin in red grape and derived beverages, representing the most common naturally occurring anthocyanins with a reduced incidence of cancer and heart diseases. Whether Pt3glc could effectively regulate glycolysis to inhibit glioblastoma multiforme (GBM) cells was investigated using the DBTRG-05MG cell line. Notably, Pt3glc displayed potent antiproliferative activity and significantly changed the protein levels related to both glycolytic metabolism and GBM cell survival. The expression of the proapoptotic protein Bcl-2-associated X protein (Bax) was increased with concomitant reduction in levels of the antiapoptotic protein Bcl-2 and caspase-3 activity.
Evidence type: In vitro and computational; no isolated clinical trials on petunidin alone.
The antioxidant properties of petunidin have been investigated principally through computational chemistry, in vitro assays, and studies on anthocyanin-rich extracts containing petunidin among other pigments. A computational investigation on the structure and antioxidant property of petunidin as a natural food colorant was performed using density functional theory (DFT) at the B3LYP/6-31+G(d,p) level. This theoretical work established that the HAT (hydrogen atom transfer) mechanism is a dominant pathway for petunidin's radical-scavenging activity, with the C3-OH group being the most active site.
Petunidin is one of the most abundant natural anthocyanins with the biological activities of anti-inflammation, anti-cancer, and anti-microbial. However, it must be noted that no controlled human clinical trials specifically assessing the antioxidant effects of isolated petunidin have been located in the scientific literature. Evidence for antioxidant effects in humans derives from studies using whole plant extracts in which petunidin is one of multiple anthocyanins present.
Evidence type: Preclinical (in vitro cell line studies); no clinical trials on petunidin in isolation.
The most studied anticancer application of petunidin-specific compounds involves glioblastoma and related cancer cell lines. Petunidin-3-O-glucoside (Pt3glc), an anthocyanin in red grape and derived beverages, caused significant changes in glioma cell morphology, leading to more pronounced apoptotic cell death via PI3K/Akt signaling.
Using the DBTRG-05MG glioblastoma cell line, Pt3glc was found to effectively regulate glycolysis to inhibit GBM cell growth. Pt3glc displayed potent antiproliferative activity and significantly changed the protein levels related to both glycolytic metabolism and GBM cell survival. This study, published in the Journal of Cellular Physiology (2019), was an in vitro investigation and its results cannot be directly applied to humans without further translational research.
Despite the abundance of studies in which various polyphenols have demonstrated excellent anticancer properties, the majority of these studies were performed in preclinical models. The bioactivities of polyphenols must also be investigated in humans because it cannot be assumed that the experimental results in cellular/animal models can be extrapolated to humans, principally due to differences in genetics and metabolism.
In summary, the anticancer evidence for petunidin remains at the preclinical stage. No human clinical trials specifically examining isolated petunidin as an anticancer intervention have been published in the indexed literature.
Evidence type: Preclinical (in vitro and animal studies); no human clinical trials.
Two recent studies have examined petunidin's role in the context of diabetic complications. Regarding diabetic retinopathy, petunidin pre-treatment significantly reduced LPS-induced cytokine secretion in BV2 retinal microglia cells and primary retinal microglia, as well as LCN2 upregulation, by suppressing activation of O-GlcNAc modification and NF-κB. The protective effect of petunidin against LPS-induced retinal microglia inflammatory response was achieved by regulating the OGT/NF-κB/LCN2 axis. These findings may contribute to the potential clinical use of petunidin in treating diabetic retinopathy. This was an in vitro study and its conclusions are preliminary.
Regarding diabetic nephropathy (DN), diabetic nephropathy is one of the most serious complications of diabetes and the leading cause of end-stage renal disease worldwide. The pathogenesis of DN is complex, and oxidative stress and ferroptosis play key roles. Petunidin is a member of the anthocyanin family and has strong antioxidant activity. However, there are no relevant studies on the use of petunidin to improve diabetic nephropathy. The aim of one study was to investigate the protective mechanism of petunidin in diabetic nephropathy. In the animal experiments, db/m and db/db mice were treated with petunidin for 8 weeks. This represents an early-stage in vivo investigation; no human data exist for this application.
Evidence type: Preclinical (animal studies with a specific petunidin glycoside); no human trials.
In rat studies, petunidin has improved learning and memory deficits, inhibited neuronal apoptosis, and alleviated symptoms by reducing oxidative stress and inflammation while increasing microglial cell viability. Petunidin-3-O-(trans-p-coumaroylrutinoside)-5-O-glucoside (PtCG) is the primary component of Lycium ruthenicum Murr., accounting for over 80% of the total anthocyanin content. Currently, most research focuses on the effects of anthocyanin extracts, with limited studies on specific anthocyanin monomers, making it challenging to elucidate the material basis and precise mechanisms of action.
Anthocyanins are well-known to have potent antioxidant and anti-inflammatory activity, which explains the various biological effects reported for these substances suggesting their antidiabetic and anticancer activities, and their role in cardiovascular and neuroprotective prevention. An in-depth look at preclinical, in vitro, in vivo, and clinical studies indicates the preventive effects of anthocyanins on cardioprotection, neuroprotection, anti-obesity, as well as their antidiabetes and anticancer effects. However, these findings apply to the broader class of anthocyanins; evidence specific to isolated petunidin in human neuroprotection studies is absent from the current literature.
Evidence type: Indirect evidence through broader anthocyanin research; no human trials with isolated petunidin.
Petunidin-containing foods and extracts are frequently studied in the context of cardiovascular health research. Petunidin-3-O-glucoside is described as representing the most common naturally occurring anthocyanins associated with a reduced incidence of cancer and heart diseases. However, this claim is derived from epidemiological associations with anthocyanin-rich dietary patterns rather than from controlled intervention trials using isolated petunidin.
A recent literature review suggests a trend for fruits rich in cyanidin, peonidin, or pelargonidin glycosides to exhibit more reproducible anti-inflammatory effects than blueberries, which contain mostly delphinidin, malvidin, and petunidin glycosides. This observation seems to be consistent with the notion that one or more phenolic acid metabolites contribute to the health effects of anthocyanin-rich fruits. This is significant because it suggests that the specific anthocyanidin structure — including petunidin's partial B-ring methylation — may modulate biological outcomes, and that petunidin-dominant preparations may have a different effect profile compared with cyanidin-dominant preparations.
Evidence type: Animal studies; no human data.
To establish a murine aging model, D-galactose was administered intraperitoneally. The anti-aging effects of PtCG were investigated through behavioral tests, biochemical indicator measurements, and histopathological observations of brain, serum, liver, and kidney tissues. The potential mechanism of action was explored by examining the expression of related proteins. These animal experiments are preliminary, and their translation to human outcomes is uncertain.
The role of petunidin in human nutrition has gained importance owing to its health-promoting effects on many chronic diseases. The potential bioactivity of petunidin depends on its absorption, metabolism, and excretion in the human body.
Anthocyanins are the least bioavailable group of flavonoids, with limited intestinal absorption due to having a positive charge in intestinal pH and excessive glycosylation. Studies investigating anthocyanin absorption by Caco-2 cells report very low absorption of these compounds. However, the bioavailability of anthocyanins may be underestimated since the metabolites formed in the course of digestion could be responsible for the health benefits associated with anthocyanins.
Peonidin glycosides have the highest relative bioavailability, followed by cyanidin, malvidin, delphinidin, and petunidin glycosides of red wine anthocyanins. This places petunidin among the less bioavailable of the common anthocyanins when consumed from red wine.
In human studies examining a wild blueberry beverage, the parent anthocyanins reached maximum plasma concentrations at around 2 hours post-ingestion, while phase II metabolites such as glucuronide conjugates of peonidin, delphinidin, cyanidin, and petunidin achieved maximum concentrations later, at 2.6 to 8.8 hours.
The specificity of selected gastrointestinal bacteria to metabolize anthocyanins will define the systemic presence of the different metabolites. Results in human studies show that metabolites resulting from microbial catabolism account for most of the absorbed compounds after dietary anthocyanin consumption. Studies examining human and rat feces have shown that protocatechuic acid, 3-hydroxyphenylpropionic acid, pyrogallol, 3,4-dihydroxybenzoic acid, and tyrosol are the main metabolites formed after colonic fermentation of berries. These studies prove that mono- and di-glycosidic anthocyanins are rapidly catabolized by colonic microbiota.
The production of O-methylated metabolites from malvidin and petunidin may increase their bioactivity compared to the parent compound. On the other hand, glycosylation and acetylation of anthocyanins, while conferring increased stability in the gastrointestinal tract, showed a decreased bioactivity.
PT shows good predicted solubility (log S = −2.328), which is favorable for oral absorption relative to many poorly soluble flavonoids. PT shows no violation to Lipinski's rule of 5, indicating its nature as an orally admissible drug.
No standardized human dosage for isolated petunidin has been established by any regulatory body or clinical guideline. Petunidin is not available as a standardized single-compound pharmaceutical or registered dietary supplement.
In the preclinical and laboratory literature, dosages used in animal and cell culture experiments have varied. In an animal study examining diabetic nephropathy, db/m and db/db mice were treated with petunidin for 8 weeks, though the specific dose in mg/kg was not available in the abstract data retrieved. In the glioblastoma in vitro study, petunidin-3-O-glucoside (Pt3glc) was tested in the DBTRG-05MG cell line at concentrations sufficient to demonstrate changes in glycolytic enzyme expression and apoptotic markers, but no human-equivalent dosage can be extrapolated from such data.
In the context of whole anthocyanin dietary supplement studies, petunidin forms a fraction of the total anthocyanin dose. In human studies on blueberry or bilberry preparations — the dietary sources richest in petunidin — typical doses range from approximately 100 mg to 500 mg of standardized anthocyanin extract, but petunidin's individual contribution within these doses has not been consistently quantified across trials.
Recent findings on the molecular mechanisms of action of petunidin in cells, pharmacological studies in animals, and clinical trials and human studies involving petunidin have been highlighted in the literature, though human clinical trials isolating petunidin's individual dose-response relationship remain limited.
Computational toxicity analysis clearly shows that petunidin is nonmutagenic, nontumorigenic, and nonirritant based on in silico modeling. PT is non-toxic in nature, and all these factors favor its use as a potential antioxidant and a drug, according to computational prediction. These findings, while informative, are theoretical and based on structural prediction software rather than empirical toxicological studies in animals or humans.
To date, there is a noticeable absence of studies specifically focusing on purified anthocyanins derived from natural sources. While findings from cyanidin safety studies offer insights into the safety considerations of anthocyanins, they may not be extrapolated to other anthocyanins such as delphinidins, malvidins, pelargonidins, peonidins, and petunidins. This is a significant limitation: the direct safety profile of purified petunidin in humans is not established in the published literature.
Due to their widespread consumption, anthocyanins have been the subject of extensive research to elucidate their various biological activities. Anthocyanins have demonstrated multifaceted biological activities, including documented evidence supporting their anti-obesity, antioxidant, anti-inflammatory, anti-diabetic, and neuroprotective activities against neurodegenerative diseases. The long-standing dietary consumption of petunidin-rich foods (berries, grapes, red wine) in diverse human populations provides a general background presumption of safety at normal dietary intake levels. However, this does not establish safety at isolated, high-dose supplemental levels.
The color and stability of anthocyanin pigments are influenced by pH, light, temperature, and structure. Petunidin's single B-ring methoxyl group provides intermediate stability relative to other anthocyanidins. Processing conditions such as heating, exposure to ultraviolet light, and alkaline pH conditions can degrade petunidin, reducing the amount of active compound present in processed food products and certain supplement formulations.
Anthocyanins are the least bioavailable group of flavonoids, with limited intestinal absorption due to having a positive charge in intestinal pH and excessive glycosylation. The low and variable bioavailability of petunidin means that the amount consumed in a supplement may differ substantially from the amount reaching systemic circulation. Individual variation in gut microbiota composition substantially influences the extent to which petunidin is converted to bioactive metabolites. Varying individual gut microbiota composition may be the reason for conflicting or contradictory results of clinical studies on effects of anthocyanins.
No specific drug interaction studies have been conducted for isolated petunidin. Petunidin has considerable bioactivity against nuclear receptor ligands while showing only moderate activity towards GPCR and ion channel modulators, suggesting theoretical potential for interactions with nuclear receptor-mediated drug metabolism. However, no empirical human pharmacokinetic interaction data for isolated petunidin have been identified in the indexed literature.
Anthocyanins extracted from plants have been used as food additives. Food additive E163 is one of the commercial additives derived from fruit anthocyanins such as grape skin. It is a purple food additive for use in producing purple-colored jam, confectioneries, and beverages. Petunidin contributes to this approved food coloring class. Its use as a food colorant within this framework has a regulatory history of generally recognized safe use in food applications at the concentrations found in natural sources and standard extract preparations.
The scientific literature on petunidin specifically — as opposed to the class of anthocyanins broadly — is at an early stage. The following critical limitations apply:
Health conditions that Petunidin may help support.
Body systems that Petunidin may help support.
Go back